SG10201509063SA - Substituted benzamides and their uses - Google Patents
Substituted benzamides and their usesInfo
- Publication number
- SG10201509063SA SG10201509063SA SG10201509063SA SG10201509063SA SG10201509063SA SG 10201509063S A SG10201509063S A SG 10201509063SA SG 10201509063S A SG10201509063S A SG 10201509063SA SG 10201509063S A SG10201509063S A SG 10201509063SA SG 10201509063S A SG10201509063S A SG 10201509063SA
- Authority
- SG
- Singapore
- Prior art keywords
- substituted benzamides
- benzamides
- substituted
- Prior art date
Links
- 229940054066 benzamide antipsychotics Drugs 0.000 title 1
- 150000003936 benzamides Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/62—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems having two or more ring systems containing condensed 1,3-oxazole rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261623517P | 2012-04-12 | 2012-04-12 | |
| US201361791823P | 2013-03-15 | 2013-03-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201509063SA true SG10201509063SA (en) | 2015-12-30 |
Family
ID=49328285
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201406518XA SG11201406518XA (en) | 2012-04-12 | 2013-04-11 | Substituted benzamides and their uses |
| SG10201509063SA SG10201509063SA (en) | 2012-04-12 | 2013-04-11 | Substituted benzamides and their uses |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201406518XA SG11201406518XA (en) | 2012-04-12 | 2013-04-11 | Substituted benzamides and their uses |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9296732B2 (fr) |
| EP (1) | EP2838534A4 (fr) |
| JP (1) | JP2015516393A (fr) |
| KR (1) | KR20150013475A (fr) |
| CN (1) | CN104411311A (fr) |
| AU (1) | AU2013245809A1 (fr) |
| CA (1) | CA2873701A1 (fr) |
| HK (1) | HK1207301A1 (fr) |
| IL (1) | IL235145A0 (fr) |
| MX (1) | MX2014012294A (fr) |
| RU (1) | RU2014141510A (fr) |
| SG (2) | SG11201406518XA (fr) |
| WO (1) | WO2013155338A2 (fr) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2627324A4 (fr) * | 2010-10-11 | 2014-05-07 | Univ Leland Stanford Junior | Benzamides substitués et leurs utilisations |
| WO2015078799A1 (fr) * | 2013-11-27 | 2015-06-04 | Bayer Pharma Aktiengesellschaft | Inhibiteurs de transport de glucose |
| WO2016028971A1 (fr) | 2014-08-21 | 2016-02-25 | Bristol-Myers Squibb Company | Dérivés rattachés de benzamide utilisés comme puissants inhibiteurs de rock |
| WO2016202935A1 (fr) | 2015-06-19 | 2016-12-22 | Bayer Pharma Aktiengesellschaft | Inhibiteurs de transport du glucose |
| WO2020113094A1 (fr) | 2018-11-30 | 2020-06-04 | Nuvation Bio Inc. | Composés pyrrole et pyrazole et leurs procédés d'utilisation |
| CA3166630A1 (fr) | 2020-01-03 | 2021-07-08 | Berg Llc | Amides polycycliques utilises en tant que modulateurs d'ube2k pour le traitement du cancer |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4172896A (en) | 1978-06-05 | 1979-10-30 | Dainippon Pharmaceutical Co., Ltd. | Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same |
| GB9217295D0 (en) | 1992-08-14 | 1992-09-30 | Wellcome Found | Controlled released tablets |
| US5541231A (en) | 1993-07-30 | 1996-07-30 | Glaxo Wellcome Inc. | Stabilized Pharmaceutical |
| US5358970A (en) | 1993-08-12 | 1994-10-25 | Burroughs Wellcome Co. | Pharmaceutical composition containing bupropion hydrochloride and a stabilizer |
| GB9315856D0 (en) | 1993-07-30 | 1993-09-15 | Wellcome Found | Stabilized pharmaceutical |
| CN1087725C (zh) | 1994-03-25 | 2002-07-17 | 同位素技术有限公司 | 用氘代方法增强药物效果 |
| US6334997B1 (en) | 1994-03-25 | 2002-01-01 | Isotechnika, Inc. | Method of using deuterated calcium channel blockers |
| US6110973A (en) | 1998-01-29 | 2000-08-29 | Sepracor | Methods for treating obesity and weight gain using optically pure (-)-bupropion |
| TW200404789A (en) | 1999-03-15 | 2004-04-01 | Axys Pharm Inc | Novel compounds and compositions as protease inhibitors |
| US6835731B2 (en) * | 2000-09-15 | 2004-12-28 | Anormed, Inc. | Chemokine receptor binding heterocyclic compounds |
| EP1369420A1 (fr) | 2002-06-06 | 2003-12-10 | Aventis Pharma Deutschland GmbH | Inhibiteurs d'interaction GPib-vWF |
| US7235558B2 (en) | 2002-06-06 | 2007-06-26 | Sanofi-Aventis Deutschland Gmbh | Inhibitors of the GPIb—vWF interaction, their preparation and use |
| TW200505446A (en) | 2003-01-17 | 2005-02-16 | Fuj Isawa Pharmaceutical Co Ltd | Inhibitor of cox |
| US20080293711A1 (en) | 2007-03-08 | 2008-11-27 | Clark Michael P | Chemokine receptor modulators |
| WO2009097113A2 (fr) * | 2008-01-28 | 2009-08-06 | New York University | Composés oxazole et thiazole utilisés comme modulateurs de la b-caténine et leurs utilisations |
| US20110105436A1 (en) | 2008-03-10 | 2011-05-05 | Auckland Uniservices Limited | Heteroaryl compounds, compositions, and methods of use in cancer treatment |
| HRP20170357T1 (hr) | 2008-10-10 | 2017-05-05 | Vm Discovery, Inc. | Sastavi i postupci za liječenje poremećaja zbog konzumacije alkohola, bolova i ostalih bolesti |
| WO2010078408A1 (fr) | 2008-12-30 | 2010-07-08 | Biogen Idec Ma Inc. | Composés hétéroaryles utiles en tant qu'inhibiteurs de kinase raf |
| WO2011011514A1 (fr) * | 2009-07-21 | 2011-01-27 | The Board Of Trustees Of The Leland Stanford Junior University | Hétéroaryl benzamides, compositions et procédés d'utilisation |
| EP2627324A4 (fr) | 2010-10-11 | 2014-05-07 | Univ Leland Stanford Junior | Benzamides substitués et leurs utilisations |
| WO2012100223A1 (fr) | 2011-01-21 | 2012-07-26 | John Irwin | Ciblage léthal synthétique de transport de glucose |
-
2013
- 2013-04-11 US US14/391,690 patent/US9296732B2/en not_active Expired - Fee Related
- 2013-04-11 CN CN201380028852.5A patent/CN104411311A/zh active Pending
- 2013-04-11 SG SG11201406518XA patent/SG11201406518XA/en unknown
- 2013-04-11 MX MX2014012294A patent/MX2014012294A/es unknown
- 2013-04-11 AU AU2013245809A patent/AU2013245809A1/en not_active Abandoned
- 2013-04-11 KR KR1020147030024A patent/KR20150013475A/ko not_active Withdrawn
- 2013-04-11 JP JP2015505920A patent/JP2015516393A/ja active Pending
- 2013-04-11 HK HK15107945.4A patent/HK1207301A1/xx unknown
- 2013-04-11 EP EP13776347.0A patent/EP2838534A4/fr not_active Withdrawn
- 2013-04-11 CA CA2873701A patent/CA2873701A1/fr not_active Abandoned
- 2013-04-11 RU RU2014141510A patent/RU2014141510A/ru not_active Application Discontinuation
- 2013-04-11 WO PCT/US2013/036229 patent/WO2013155338A2/fr not_active Ceased
- 2013-04-11 SG SG10201509063SA patent/SG10201509063SA/en unknown
-
2014
- 2014-10-19 IL IL235145A patent/IL235145A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HK1207301A1 (en) | 2016-01-29 |
| SG11201406518XA (en) | 2014-11-27 |
| MX2014012294A (es) | 2015-06-05 |
| CA2873701A1 (fr) | 2013-10-17 |
| WO2013155338A3 (fr) | 2013-12-27 |
| JP2015516393A (ja) | 2015-06-11 |
| WO2013155338A8 (fr) | 2015-01-08 |
| EP2838534A4 (fr) | 2015-11-11 |
| AU2013245809A1 (en) | 2014-11-06 |
| KR20150013475A (ko) | 2015-02-05 |
| WO2013155338A2 (fr) | 2013-10-17 |
| EP2838534A2 (fr) | 2015-02-25 |
| RU2014141510A (ru) | 2016-06-10 |
| US9296732B2 (en) | 2016-03-29 |
| US20150072976A1 (en) | 2015-03-12 |
| IL235145A0 (en) | 2014-12-31 |
| CN104411311A (zh) | 2015-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL235826A0 (en) | Diazaspirocycloalkane and azaspirocycloalkane | |
| IL234628A0 (en) | Imidazolyl-pyrimidines are converted into amino-indolyl and their use as drugs | |
| IL236616A0 (en) | 5-aminotetrahydroquinoline-2-new carboxylic acids and their use | |
| IL237309A0 (en) | Benzocyclooctyne compounds and uses thereof | |
| IL237926A0 (en) | Combinations and their uses | |
| AP2015008406A0 (en) | Benzamides | |
| ZA201302854B (en) | Substituted benzamides and their uses | |
| ZA201405392B (en) | Substituted phenylimidazopyrazoles and use thereof | |
| IL235145A0 (en) | Converted benzamides and their use | |
| SG11201504482VA (en) | Beta-hexosyl-transferases and uses thereof | |
| PL2882708T3 (pl) | Nowe związki i ich zastosowania | |
| GB201301571D0 (en) | Product and use | |
| PL2830587T3 (pl) | Kompozycja o balansującym i ochronnym wpływie na skórę | |
| GB201222541D0 (en) | Kiddibidet and pottibidet | |
| IL218974A0 (en) | Conaction bitwen coutch and playels | |
| GB201202021D0 (en) | Co-sleeper and breastfeeder | |
| GB201214749D0 (en) | Compounds and their uses | |
| GB201213726D0 (en) | Novel compounds and their use | |
| GB201215414D0 (en) | Composition and use | |
| GB201222342D0 (en) | Compounds and uses thereof | |
| GB201206973D0 (en) | New compounds and uses | |
| GB201207075D0 (en) | New compounds and uses | |
| GB201206055D0 (en) | New compounds and uses | |
| AP2015008228A0 (en) | Novel 5-aminotetrahydroquinoline-2-carboxylic acids and use thereof | |
| GB201220504D0 (en) | Product and use thereof |